​

ZyVersa Therapeutics Ownership | Who Owns ZyVersa Therapeutics?

OverviewFinancialsChart

ZyVersa Therapeutics Ownership Summary

ZyVersa Therapeutics is owned by 0.02% insiders, and 99.98% retail investors.

ZVSA Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockZyVersa Therapeutics-0.02%99.98%
SectorHealthcare Stocks 35.49%11.75%52.76%
IndustryBiotech Stocks 34.83%11.71%53.46%

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20251-83.33%7-99.99%-9.09%1-80.00%--
Jun 30, 20256-14.29%66,068-5.45%-78791.67%566.67%--100.00%
Mar 31, 20257-12.50%69,877-13.82%-61557.14%3-57.14%2-
Dec 31, 2024860.00%81,0852594.75%-26947500.00%775.00%--
Sep 30, 2024525.00%3,009-70.80%-146000.00%4---

Insider Transactions Trends

DateBuySell
2023 Q1--
2022 Q4--
2022 Q1--

ZVSA Ownership FAQ

Who Owns ZyVersa Therapeutics?

ZyVersa Therapeutics shareholders are primarily institutional investors at 0%, followed by 0.02% insiders and 0% retail investors. The average institutional ownership in ZyVersa Therapeutics's industry, Biotech Stocks , is 34.83%, which ZyVersa Therapeutics falls below.

Does Blackrock own ZyVersa Therapeutics?

BlackRock is not among the top 10 institutional shareholders of ZyVersa Therapeutics.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools